Written question asked by Catherine West (Labour) on Wednesday, 6 January 2021, in the House of Commons. It was due for an answer on Monday, 11 January 2021. It was answered by Jo Churchill (Conservative) on Friday, 26 March 2021 on behalf of the Department of Health and Social Care.
Epilepsy: Cannabis
- Question
-
To ask the Secretary of State for Health and Social Care, what urgent steps he is taking to support families to continue to access Bedrolite oil for the treatment of severe epilepsy following the end of the transition period.
- Answer
-
The Department, supported by the British Embassy to The Hague, has reached an agreement with the Dutch Government to allow the continued supply of Bedrocan oils, a form of unlicensed medicinal cannabis, against United Kingdom prescriptions for existing patients until 1 July 2021. The medicines supply chain has ensured that there continues to be good supply of licensed and unlicensed cannabis-based medicines after the transition period.
My Written Ministerial Statement of 26 January (HCWS734) provided an update on action taken by the Government on supply from the Netherlands and next steps to establish a more permanent solution.
Secondary information
- Type
- Written question
- Reference
- 134037
- Session
- 2019-21
- Related items
-
Update on supply of Medicinal Cannabis from The Netherlands
Tuesday, 26 January 2021
Written statements
House of Commons
- Subjects
- Cannabis Epilepsy Medical treatments
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2024-02-26 15:16:32 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/134037
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/134037
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2019-21/134037